#coinfection

Researchers compared health outcomes among people with HIV, including those with and without hepatitis C.

Large European study finds that more than 1 in 10 people with HIV acquire HCV again.

Cure rates are high, but some young people already have advanced liver damage by the time they’re treated.

CANN will present its annual report on the state of co-infection in the United States.

An NIH-sponsored peer-recruitment study is part of a larger push to figure out how to drive up the viral suppression rate in the U.S.

Pharmacists oversaw the delivery of hepatitis C treatment in a recent study.

European and U.S. guidelines recommend that all those with cirrhosis undergo biannual screening for liver cancer.

Living with cancer and HIV is the theme of this issue.

The Office of HIV and AIDS Malignancy at the National Cancer Institute coordinates cancer and HIV research.

People living with HIV are also facing cancer as they age.

People with the chronic inflammatory lung disease are about two times more likely to have a heart attack.

A study of gay and bi men with HIV in Australia who had been cured of hep C found they associated hep C with injection drug use.

Chronic inflammation is associated with numerous harms.

Researchers used mathematical modeling to analyze the benefits of treating with buprenorphine/naloxone on-site.

Gay and bisexual men with HIV who are cured of hep C are reinfected at a high rate.

Four things you should know to be #HepAware.